1. Pink Sheet
  2. >>Market Access

Open-Source Rx Value Model Designed To Encourage 'More Productive' Discussions

 
• By Cathy Kelly

Industry-funded Open-Source Value Project aims to disseminate tools to the marketplace for customized value assessments, as opposed to offering a specific estimate of value for pricing and coverage decisions.

Pills and dollars

The Innovation and Value Initiative's open-source tool for measuring the value of prescription drugs could serve as a counterpoint to the assessments conducted by the Institute for Clinical and Economic Review and others.

Known as the Open-Source Value Project, the tool was introduced in the fall with funding from the health consultancy Precision...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access

Medicare Part D LIS Access Threatened By House Budget Bill’s Medicaid Obstacles

 
• By Cathy Kelly

An unintended consequence of a provision framed as an administrative change in the bill could significantly reduce medication adherence among low-income older adults and increase mortality, a study found.

Pharma’s Protests Fall Flat As UK Locks In High Rebate Rates

 
• By Neena Brizmohun

Despite pushback by industry, the government is standing by its new statutory scheme rebate rates for branded medicines, including one that doubles the rate that companies must repay on the sales of newer products to the National Health Service to 31.3%.

Argentina Speeds Up Market Access Process

 
• By Francesca Bruce

Companies operating in Argentina may get their medicines to the market more quickly thanks to new updates to the medicines authorization system.